Individual Lab Report Ci-Trol Nov,2016. Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC Your Lab

Size: px
Start display at page:

Download "Individual Lab Report Ci-Trol Nov,2016. Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC Your Lab"

Transcription

1 Individual Lab Report Ci-Trol Nov,2016 ST VINCENT MEDICAL CENTER LABORATORY(LAB# 7300 ) 2131 WEST THIRD STREET LOS ANGELES CA USA Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC SYSMEX CA , DADE THROMBIN Nov SYSMEX CA 1500/7000, DADE THROMBIN Period Avg. SD Avg. CV s # Points SDI CVI Nov Nov Individual means in peer , , , , , , , Abnormal Fbg Control - Lot# LFC SYSMEX CA , DADE THROMBIN Nov N N SYSMEX CA 1500/7000, DADE THROMBIN Period Avg. SD Avg. CV s # Points SDI CVI Nov Nov Individual means in peer , , , , , , , APTT (seconds) Ci-Trol 1 - Lot# SYSMEX CA , DADE ACTIN FSL Nov - N SYSMEX CA 1500/7000, DADE ACTIN FSL Period Avg. SD Avg. CV s # Points SDI CVI Nov Individual means in peer , , , , , Nov SYSMEX CA , DADE ACTIN FSL Nov SYSMEX CA 1500/7000, DADE ACTIN FSL Period Avg. SD Avg. CV s # Points SDI CVI Nov Nov Individual means in peer , , , , , , , Total Error Graph (= ) CLIA CLIA Total Error Graph (= ) CLIA CLIA Total Error Graph (= ) CLIA CLIA Total Error Graph (= ) CLIA CLIA Refer to the Siemens Hemostasis QAP Report Appendix for report definitions and calculations. Print Date & Time: 27-Jul-18 6:42:39 AM Part No.: D53852 Page: 1

2 Individual Lab Report Ci-Trol Nov,2016 ST VINCENT MEDICAL CENTER LABORATORY(LAB# 7300 ) 2131 WEST THIRD STREET LOS ANGELES CA USA APTT (seconds) SYSMEX CA , DADE ACTIN FSL Nov SYSMEX CA 1500/7000, DADE ACTIN FSL Period Avg. SD Avg. CV s # Points SDI CVI Nov Nov Individual means in peer , , , , , , , Clauss Fibrinogen (mg/dl) Ci-Trol 1 - Lot# SYSMEX CA , DADE THROMBIN Nov - N SYSMEX CA 1500/7000, DADE THROMBIN Period Avg. SD Avg. CV s # Points SDI CVI Nov Nov Individual means in peer , , , , Prothrombin Time (seconds) Ci-Trol 1 - Lot# SYSMEX CA , DADE INNOVIN Nov - N SYSMEX CA 1500/7000, DADE INNOVIN Period Avg. SD Avg. CV s # Points SDI CVI Nov Individual means in peer , , , , , Nov SYSMEX CA , DADE INNOVIN Nov SYSMEX CA 1500/7000, DADE INNOVIN Period Avg. SD Avg. CV s # Points SDI CVI Nov Nov Individual means in peer , , , , , , , Total Error Graph (= ) CLIA CLIA Total Error Graph (= ) CLIA CLIA Total Error Graph (= ) CLIA CLIA Total Error Graph (= ) CLIA CLIA Refer to the Siemens Hemostasis QAP Report Appendix for report definitions and calculations. Print Date & Time: 27-Jul-18 6:42:39 AM Part No.: D53852 Page: 2

3 Individual Lab Report Ci-Trol Nov,2016 ST VINCENT MEDICAL CENTER LABORATORY(LAB# 7300 ) 2131 WEST THIRD STREET LOS ANGELES CA USA Prothrombin Time (seconds) SYSMEX CA , DADE INNOVIN Nov SYSMEX CA 1500/7000, DADE INNOVIN Period Avg. SD Avg. CV s # Points SDI CVI Nov Nov Individual means in peer , , , , , , , Total Error Graph (= ) CLIA CLIA QAP Reports are designed primarily to summarize data on Siemens Hemostasis Controls. The Statistics are calculations from user input and are provided as a service to customers. No claim is made as to the validity of values, tests and methods beyond those specifically identified on Siemens Hemostasis Control inserts and product literature. Refer to the Siemens Hemostasis QAP Report Appendix for report definitions and calculations. Print Date & Time: 27-Jul-18 6:42:39 AM Part No.: D53852 Page: 3

4

5 Report Appendix DATA CODES Any code that may appear with data on Siemens Hemostasis QAP reports is listed here with a brief description. 1 This symbol prints next to the Avg when the number of peers in the peer group is 10 or fewer, signifying a small peer group. For these small sample sizes, the individual means of each peer in the group are printed at the end of the data for the control level. "-" This statistic was Not Calculated for the indicated data collection period due to the presence of incongruent data in the calculation. C This data has been changed or added by Siemens Hemostasis QAP at the request of your laboratory. G L N P S This value did not pass the Gross Outlier Check, which excludes extremely discrepent data that falls outside of present limits for each test. This data was not processed and is not included in QAP Reports. This value did not pass the Laboratory Outlier Check, which excludes values more than +/- 3 standard deviations from the lab s mean for the month. This value was excluded from the calculation of the lab s mean and SD for this month. The SD and CV for a set of control data points for an individual lab are not displayed when the number of points for the set is less than five. Your lab s mean did not pass the Outlier Check, which excludes lab means from peer statistics that are discrepant from the average peer mean. Your lab s All Shift mean did not pass the Outlier Check, which excludes lab means from peer statistics that are discrepent from the average peer mean. Data from all shifts has been excluded from the peer statistics. DEFINITIONS Avg. CV CVI The peer average mean is calculated by averaging the individual means in a peer group. Comparing the lab mean to the peer average can aid in evaluating analytical accuracy. The coefficient of variation is the SD expressed as a percentage of the mean and is calculated by dividing the SD by the mean and multiplying by 100. It is useful in evaluating precision. The coefficient of variation index compares the lab s CV to the peer group median CV for evaluating precision. The CVI calculation is: Lab CV Average CV Avg. CV Lot-to-Date describes a data collection period which includes all QC data received thus far for this control lot, either for the lab or the peer, as indicated. The peer average CV (coefficient of variation) is calculated by averaging the individual CV s in a peer group. Comparing the lab CV to the peer average CV aids in evaluationg precision. Print Date & Time: 27-Jul-18 6:42:39 AM Part No.: D53865 Page: 1

6 Report Appendix For Chemistry tests, the statistics for this peer group category are calculated by combining data submitted from peers using the same method principle, with any instrument and reagent. For Hemostasis tests, the statistics for this peer group category are calculated by combining data submitted from peers using the same method principle and reagent, with any instrument. SD SD SDI The SD is the standard deviation (SD) of all the acceptable current or cumulative () lab means used in the calculation of the, or J&J Vitros standard deviation index (SDI). The standard deviation for a lab represents the spread of a set of individual data points around their mean. It is useful in evaluating precision. The standard deviation index compares the lab s mean to the peer group average mean for evaluating accuracy. The reports identify the peer group used in the SDI calculation. The SDI calculation is: Lab mean - Avg. SD Total Error (TE) The statistics for this peer group category are calculated by combinig data submitted from peers using the same or similarly performing instrumentation, and the same reagent and reaction temperature (when applicable). Total Error (TE) refers to the total analytical error of a lab s analytical method and may be used to assess its inaccuracy and imprecision. The Total Error Graph compares the Total Error of the lab s analytical method to the Total Error Limits (calculated using the mean). To assess the acceptability of the lab s Total Error, the lab s mean +/-2 SD range is compared to the Total Error Limits. This range should be within the Total Error Limits. The Total Error Limits are calculated using test performance guidelines from one of the following: U.S. CLIA, Medical Society of Germany or +/- 3 SD. Using these guidelines, the lower and upper limits are established with this calculation: the Average +/- test specific guidelines. When such guidelines are not available, the limits are not calculated. When a Total Error Limit is exceeded, it may be necessary to investigate for sources of either inaccuracy or imprecision. While this information may assist with predicting proficiency testing performance due to peer and methodological differences, it is suggested that discretion be used in interpretation. In addition, the lab must define its own analytical goals for minimizing bias and imprecision, and medical decision levels. Print Date & Time: 27-Jul-18 6:42:39 AM Part No.: D53865 Page: 2

Worldwide Report Coagulation Lot Exp 31 Oct 2018

Worldwide Report Coagulation Lot Exp 31 Oct 2018 April 0 Worldwide Report Coagulation Lot 780 Exp Oct 08 Activated Partial Thromboplastin Time (APTT) Diagnostica Stago C.K. Prest Seconds 0.7 0.89.8 9 0.7 0.89.8 9 8.8..7 8.8..7 9.90 0.97.0 9.90 0.97.0

More information

Method Comparison Report Semi-Annual 1/5/2018

Method Comparison Report Semi-Annual 1/5/2018 Method Comparison Report Semi-Annual 1/5/2018 Prepared for Carl Commissioner Regularatory Commission 123 Commission Drive Anytown, XX, 12345 Prepared by Dr. Mark Mainstay Clinical Laboratory Kennett Community

More information

INTERNAL QUALITY CONTROL ( Q I C) QC)

INTERNAL QUALITY CONTROL ( Q I C) QC) EXTERNAL QUALITY ASSESSMENT PROGRAM (EQAP) BIOCHEMISTRY DEPARTMENT R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty TWO COMPLEMENTARY COMPONENETS OF TQM ARE Internal Quality Control (IQC)

More information

Determination of APTT factor sensitivity the misguiding guideline

Determination of APTT factor sensitivity the misguiding guideline International Journal of Laboratory Hematology ORIGINAL ARTICLE The Official journal of the International Society for Laboratory Hematology INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Determination

More information

Guide to Fulfillment of Measurement Uncertainty

Guide to Fulfillment of Measurement Uncertainty DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 ext. 2635 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca

More information

QUANTIFYING THE EFFECT OF SETTING QUALITY CONTROL STANDARD DEVIATIONS GREATER THAN ACTUAL STANDARD DEVIATIONS ON WESTGARD RULES

QUANTIFYING THE EFFECT OF SETTING QUALITY CONTROL STANDARD DEVIATIONS GREATER THAN ACTUAL STANDARD DEVIATIONS ON WESTGARD RULES AACC24 QUANTIFYING THE EFFECT OF SETTING QUALITY CONTROL STANDARD DEVIATIONS GREATER THAN ACTUAL STANDARD DEVIATIONS ON WESTGARD RULES Graham Jones Department of Chemical Pathology, St Vincent s Hospital,

More information

METHOD VALIDATION CASE

METHOD VALIDATION CASE METHOD VALIDATION CASE METHOD VALIDATION PROTOCOL CLIA Regulation 493.1253 (2) 1.Accuracy (closeness to true/comparative method) 2.Precision (reproducibility) 3.Reference Interval 4.Reportable range (linearity,

More information

Cardiac Assessment Controls

Cardiac Assessment Controls Bio-Rad Laboratories CARDIAC ASSESSMENT CONTROLS Cardiac Assessment Controls Value Assigned for Clinical Laboratory and Point of Care Test Systems Solving the Challenges of Troponin I Testing for the Central

More information

Use of PSI on CS instruments

Use of PSI on CS instruments Johan Claes, Version 01, 1 st September 2016 User day hemostasis 2016 Use of PSI on CS instruments Restricted Siemens Healthcare GmbH, 2016 Hemostasis Lab Challenges Preanalytical problems in Haemostasis

More information

Internal Quality Control in the Haemostasis laboratory. Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation

Internal Quality Control in the Haemostasis laboratory. Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation Internal Quality Control in the Haemostasis laboratory Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation Why do we need Quality control? Philadelphia Enquirer Aug

More information

USING THE ACCESS AMH ASSAY IN YOUR LABORATORY

USING THE ACCESS AMH ASSAY IN YOUR LABORATORY INFORMATION BULLETIN USING THE ACCESS AMH ASSAY IN YOUR LABORATORY ///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

More information

METHOD VALIDATION CASE

METHOD VALIDATION CASE METHOD VALIDATION CASE METHOD VALIDATION PROTOCOL CLIA Regulation 493.1253 (2) 1.Accuracy (closeness to true/comparative method) 2.Precision (reproducibility) 3.Reference Interval 4.Reportable range (linearity,

More information

Setting of quality standards

Setting of quality standards Setting of quality standards Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney AACB ASM Adelaide October 2014 Setting of Quality Standards - 2013 The 2013 QC workshop revealed

More information

Presented by Marcelo Cardona, MT(ASCP) Johns Hopkins University

Presented by Marcelo Cardona, MT(ASCP) Johns Hopkins University Presented by Marcelo Cardona, MT(ASCP) Johns Hopkins University Alert or critical values represent those assay results that require prompt, rapid clinical attention to avert significant study-participant

More information

Y. ZHAO, G. LV SUMMARY

Y. ZHAO, G. LV SUMMARY International Journal of Laboratory Hematology ORIGINAL ARTICLE The Official journal of the International Society for Laboratory Hematology INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Influence of temperature

More information

Polymer Technology Systems, Inc. CardioChek PA Comparison Study

Polymer Technology Systems, Inc. CardioChek PA Comparison Study Polymer Technology Systems, Inc. CardioChek PA Comparison Study Evaluation Protocol: Accuracy Precision Clinical Correlation PTS Panels Lipid Panel Test Strips For Use in Comparisons to a Reference Laboratory

More information

A validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls

A validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls A validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls Shyamali Pal R B Diagnostic Private Limited, Lake Town, Kolkata, India INFO ABSTRACT Corresponding

More information

Patricia C. Fallest-Strobl, 1 Elin Olafsdottir, 2 Donald A. Wiebe, 1 and James O. Westgard 1 * Lipoproteins

Patricia C. Fallest-Strobl, 1 Elin Olafsdottir, 2 Donald A. Wiebe, 1 and James O. Westgard 1 * Lipoproteins Clinical Chemistry 43:11 2164 2168 (1997) Lipids and Lipoproteins Comparison of NCEP performance specifications for triglycerides, HDL-, and LDL-cholesterol with operating specifications based on NCEP

More information

College of American Pathologists (CAP) GH2 Survey Data: (updated 12/09) 2009 GH2-B (fresh pooled samples) * = NGSP certified at the time of the survey

College of American Pathologists (CAP) GH2 Survey Data: (updated 12/09) 2009 GH2-B (fresh pooled samples) * = NGSP certified at the time of the survey College of American Pathologists (CAP) GH2 Survey Data: (updated 12/09) The American Diabetes Association (ADA) recommends that laboratories use only HbA1c assay methods that have been NGSP certified and

More information

LOGO. Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University & Thai Society of Clinical Pathology

LOGO. Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University & Thai Society of Clinical Pathology LOGO Improvement of Coagulation Lab Practice in Thailand via Thailand NEQAS for Blood Coagulation : 4-year Experience Nisarat Opartkiattikul MD,PhD Panutsaya Tientadakul, MD. Department of Clinical Pathology,

More information

Use of PSI on CS instruments

Use of PSI on CS instruments Johan Claes, Version 01, 1 st September 2016 User day hemostasis 2016 Use of PSI on CS instruments Restricted Siemens Healthcare GmbH, 2016 Hemostasis Lab Challenges Preanalytical problems in Haemostasis

More information

Evaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System

Evaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System Evaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System Grace DeSantis, PhD Lisa Croner, PhD Michealle Havenhill, BA Shari Kipp, BSc (Honours) MBA Inverness Medical,

More information

Two Important Statistics

Two Important Statistics Two Important Statistics 70% 40% 0 Quality Control & YOU David Plaut Fall, 2012 davidplaut@yahoo.com 1 11 Why do physicians order laboratory tests? 2 2 Why do Physicians Order Laboratory Tests? 1. Patients

More information

METHOD VALIDATION: WHY, HOW AND WHEN?

METHOD VALIDATION: WHY, HOW AND WHEN? METHOD VALIDATION: WHY, HOW AND WHEN? Linear-Data Plotter a,b s y/x,r Regression Statistics mean SD,CV Distribution Statistics Comparison Plot Histogram Plot SD Calculator Bias SD Diff t Paired t-test

More information

Forum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007

Forum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007 Forum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007 Thomas J. Spira, M.D. International Laboratory Branch Global AIDS Program Centers for Disease

More information

Bio-Rad Laboratories. Cardiac Assessment Controls. Value Assigned for Clinical Laboratory and Point of Care Test Systems

Bio-Rad Laboratories. Cardiac Assessment Controls. Value Assigned for Clinical Laboratory and Point of Care Test Systems Bio-Rad Laboratories Cardiac Assessment Controls Cardiac Assessment Controls Value Assigned for Clinical Laboratory and Point of Care Test Systems Solving the Challenges of Troponin I Testing for the Central

More information

Determination of hemoglobin is one of the most commonly

Determination of hemoglobin is one of the most commonly ORIGINAL ARTICLE Multiple-Site Analytic Evaluation of a New Portable Analyzer, HemoCue Hb 201+, for Point-of-Care Testing Sten-Erik Bäck, PhD,* Carl G. M. Magnusson, PhD, Lena K. Norlund, MD, PhD, Henning

More information

NICO /14 Nipro Diagnostics, Inc.

NICO /14 Nipro Diagnostics, Inc. Clinical Performance of the TRUEresult twist Blood Glucose Monitoring System () Using ISO 15197:13 Criteria for Accuracy Utilizing GDH-FAD Enzyme NICO-8 1/1 Nipro Diagnostics, Inc. NICO_8_mmol.indd CLINICAL

More information

(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)

(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%) cobas b system - performance evaluation Study report from a multicenter evaluation of the new cobas b system for the measurement of HbAc and lipid panel Introduction The new cobas b system provides a point-of-care

More information

Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips

Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips Sponsored by Arthur Roberts, MD of The Living Heart Foundation The Living Heart

More information

Insights on the Quality of Coagulation Testing

Insights on the Quality of Coagulation Testing Insights on the Quality of Coagulation Testing Piet Meijer ECAT Foundation The Netherlands No conflicts of interest HAEMOSTATIC BALANCE BLEEDING HAEMOSTATIC BALANCE THROMBOSIS HAEMOSTATIC BALANCE Thrombosis

More information

Recommended Additional EUA QC checks for Zika MAC-ELISA. Wendi Kuhnert, PhD Co-Lead, Zika Laboratory Task Force

Recommended Additional EUA QC checks for Zika MAC-ELISA. Wendi Kuhnert, PhD Co-Lead, Zika Laboratory Task Force Recommended Additional EUA QC checks for Zika MAC-ELISA Wendi Kuhnert, PhD Co-Lead, Zika Laboratory Task Force Current Plans 3 Phase approach to standardize the Zika MAC-ELISA Phase 1: Distribution of

More information

Technical Bulletin. Cholesterol Reference Method Laboratory Network (CRMLN) Overview. TB Rev. 0

Technical Bulletin. Cholesterol Reference Method Laboratory Network (CRMLN) Overview. TB Rev. 0 Technical Bulletin Reference Method Laboratory Network (CRMLN) Overview TB000020 Rev. 0 Reference Method Laboratory Network (CRMLN) - General Information With guidance from the US Centers for Disease Control

More information

CLINITEK Novus Automated Urine Chemistry Analyzer

CLINITEK Novus Automated Urine Chemistry Analyzer CLINITEK, Atlas, Novus, Status+, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc. or its affiliates. All other trademarks are properties of their respective owners. Product

More information

The analytical phase

The analytical phase The analytical phase Result interpretation Test request Result Sampling Black box: the lab ANALYTICAL PHASE The CASE Uncle Pete, 67 years old Marked abdominal pain 8 pm, ED Acute abdomen? Assessment (+

More information

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26 1 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Viral Load Quality Assessment Program Summary

More information

EQAS. Hemoglobin Program (BC80) Cycle 12: December 2014 December 2015 Sample No: 1 Sample Date: 17 Dec 14. Exceptions. Customer Information

EQAS. Hemoglobin Program (BC80) Cycle 12: December 2014 December 2015 Sample No: 1 Sample Date: 17 Dec 14. Exceptions. Customer Information (BC80) : December 2014 December 20 Exceptions None at this time. Legend: No Warnings Missing Result Late Results < < > * Amended Result (per participant s request) News Customer Information Please refer

More information

Uncertainty vs. total error in judging performance of participants Milano th International Meeting, CIRME

Uncertainty vs. total error in judging performance of participants Milano th International Meeting, CIRME Uncertainty vs. total error in judging performance of participants Milano 2015 9th International Meeting, CIRME Sverre Sandberg, Noklus / EFLM Bergen Norway 1 A pragmatic approach in judging performance

More information

Evaluation Report: Eurolyser CRP test (ST0100 and ST0102) on. CUBE analyser (CA0100)

Evaluation Report: Eurolyser CRP test (ST0100 and ST0102) on. CUBE analyser (CA0100) Evaluation Report: Eurolyser CRP test (ST0100 and ST0102) on CUBE analyser (CA0100) Location Location: Eurolyser Diagnostica GmbH Operators: Simone Wieser; Franz Helminger; Michael Gruber Date: July-November

More information

Hemostasis Test Validation, Performance and Reference Intervals

Hemostasis Test Validation, Performance and Reference Intervals Hemostasis Test Validation, Performance and Reference Intervals Richard A. Marlar, Ph.D. Pathology and Laboratory Medicine Oklahoma City VA Medical Center University of Oklahoma Health Sciences Center

More information

Farouk AL Quadan lecture 3 Implentation of

Farouk AL Quadan lecture 3 Implentation of How to implement a program? Establish written policies and procedures Assign responsibility for monitoring and reviewing Train staff Obtain control materials Collect data Set target values (mean, SD) Establish

More information

HEMOCHRON. Whole Blood Coagulation Systems

HEMOCHRON. Whole Blood Coagulation Systems HEMOCHRON Whole Blood Coagulation Systems Citrated Activated Partial Thromboplastin Time (APTT) Cuvette Correlation Protocol for HEMOCHRON Microcoagulation Instruments MSIG:131 10/06 Dear Medical Professional:

More information

Third Party Controls for Your Dade Behring Systems

Third Party Controls for Your Dade Behring Systems Bio-Rad Laboratories Q U A L I T Y C O N T R O L Third Party Controls for Your Dade Behring Systems The Complete QC Solution from Bio-Rad Laboratories Bio-Rad has the control you need for your Dade Behring

More information

Week 17 and 21 Comparing two assays and Measurement of Uncertainty Explain tools used to compare the performance of two assays, including

Week 17 and 21 Comparing two assays and Measurement of Uncertainty Explain tools used to compare the performance of two assays, including Week 17 and 21 Comparing two assays and Measurement of Uncertainty 2.4.1.4. Explain tools used to compare the performance of two assays, including 2.4.1.4.1. Linear regression 2.4.1.4.2. Bland-Altman plots

More information

How Good is your INR? The Use of Certified Plasmas in PT/INR Testing. INR System. How Good is your INR? Outline

How Good is your INR? The Use of Certified Plasmas in PT/INR Testing. INR System. How Good is your INR? Outline How Good is your INR? The Use of Certified Plasmas in PT/INR Testing Dot Adcock, MD Esoterix Coagulation Mayo/NASCOLA Coagulation Testing Quality Conference April 25, 2007 How Good is your INR? The Use

More information

CCQM-K11: Key Comparison on the Determination of Total Glucose in Human Serum. Final Report May 2003

CCQM-K11: Key Comparison on the Determination of Total Glucose in Human Serum. Final Report May 2003 CCQM-K11: Key Comparison on the Determination of Total Glucose in Human Serum Final Report May 2003 Michael Welch, Lorna Sniegoski, Reenie Parris, and Willie May Analytical Chemistry Division Chemical

More information

Cardiac Assessment Controls A critical element of reliable cardiac testing

Cardiac Assessment Controls A critical element of reliable cardiac testing Cardiac Assessment Controls Cardiac Assessment Controls A critical element of reliable cardiac testing Choose the products best suited for your cardiac assessment needs Each year, 17.7 million people on

More information

GlucoMen LX PLUS blood glucose and blood ketone meter. Accuracy Evaluation to New ISO 15197:2013, with Technical and Specification Data

GlucoMen LX PLUS blood glucose and blood ketone meter. Accuracy Evaluation to New ISO 15197:2013, with Technical and Specification Data GlucoMen LX PLUS: Accuracy Evaluations to ISO 15197:2013 with Technical and Specification Data GlucoMen LX PLUS blood glucose and blood ketone meter Accuracy Evaluation to New ISO 15197:2013, with Technical

More information

SQA-V Gold Semiannual Validation/Proficiency/QC Recommendations

SQA-V Gold Semiannual Validation/Proficiency/QC Recommendations MEDICAL ELECTRONIC SYSTEMS 5757 W. Century Blvd. Suite 805 Los Angeles, CA. 90045 Remember, it ALL Started with a Sperm! www.mes global.com SQA-V Gold Semiannual Validation/Proficiency/QC Recommendations

More information

Accuracy and Precision Performance of the Accu-Chek Mobile System. Introduction. Method

Accuracy and Precision Performance of the Accu-Chek Mobile System. Introduction. Method Accuracy and Precision Performance of the Accu-Chek Mobile System I. ACCURACY The accuracy of the system was assessed according to ISO 15197. Introduction The purpose of this study was to determine the

More information

Multicenter evaluation of the CoaguChek Prothrombin Time (PT) Test on the CoaguChek Pro II meter White paper

Multicenter evaluation of the CoaguChek Prothrombin Time (PT) Test on the CoaguChek Pro II meter White paper Multicenter evaluation of the CoaguChek Prothrombin Time (PT) Test on the CoaguChek Pro II meter White paper Contents Summary...3 Introduction...4 Intended use...4 Fields of application...4 Enhanced features

More information

Basic knowledge of POCT instuments. The Tide Resort Bangsan Beach 18 June 2009

Basic knowledge of POCT instuments. The Tide Resort Bangsan Beach 18 June 2009 Basic knowledge of POCT instuments The Tide Resort Bangsan Beach 18 June 2009 1 POCT instruments concepts Point of care testing Diagnostic medical devices used at or near the site of patient care Bed site,

More information

1. PROTOCOL. Comparison Study Summary. Tuality Healthcare 324 SE 9 th Ave. Suite E Hillsboro, OR July 30, 2014

1. PROTOCOL. Comparison Study Summary. Tuality Healthcare 324 SE 9 th Ave. Suite E Hillsboro, OR July 30, 2014 Comparison Study Summary Tuality Healthcare 324 SE 9 th Ave. Suite E Hillsboro, OR 97123 July 30, 2014 1. PROTOCOL This study was conducted on July 24 th, 2014 at Tuality Healthcare, Hillsboro, OR. The

More information

System accuracy evaluation of FORA Test N Go Blood Glucose Monitoring System versus YSI 2300 STAT Plus glucose analyzer following ISO 15197:2013

System accuracy evaluation of FORA Test N Go Blood Glucose Monitoring System versus YSI 2300 STAT Plus glucose analyzer following ISO 15197:2013 System accuracy evaluation of FORA Test N Go Blood Glucose Monitoring System versus YSI 2300 STAT Plus glucose analyzer following ISO 15197:2013 Abstract Objective: The goal of the study was to assess

More information

White Paper, Evaluation of WaveSense JAZZ Blood Glucose Monitoring System Analytical Performance to EN ISO 15197:2015 Standard

White Paper, Evaluation of WaveSense JAZZ Blood Glucose Monitoring System Analytical Performance to EN ISO 15197:2015 Standard White Paper, Evaluation of WaveSense JAZZ Blood Glucose Monitoring System Analytical Performance to EN ISO 15197:2015 Standard 7500-10032 Rev F Table of Contents Executive Summary 3 Changes introduced

More information

FreeStyle Lite A Blood Glucose Meter That Requires No Coding

FreeStyle Lite A Blood Glucose Meter That Requires No Coding Journal of Diabetes Science and Technology Volume 2, Issue 4, July 2008 Diabetes Technology Society SYMPOSIUM Shridhara, Ph.D. Abstract Background: Abbott Diabetes Care introduced the FreeStyle Lite blood

More information

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2017Oct27

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2017Oct27 1 The National Laboratory for HIV Reference Services is Accredited to ISO 15189 and ISO 17043 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology

More information

Customer Bulletin. Questions/Comments? Please call Customer Service at (Direct) or (Toll-free inside USA).

Customer Bulletin. Questions/Comments? Please call Customer Service at (Direct) or (Toll-free inside USA). Customer Bulletin Assignment of Ranges for PTS Panels Multi-Chemistry Controls (Cat. No./REF 721) and PTS Panels Controls (Cat. No./REF 722) Background: PTS Panels Multi-Chemistry Controls and Controls

More information

Equivalent Accuracy Evaluation of FORA Premium V10 Blood Glucose Monitoring System as Compared to Fora V30 Blood Glucose Monitoring System

Equivalent Accuracy Evaluation of FORA Premium V10 Blood Glucose Monitoring System as Compared to Fora V30 Blood Glucose Monitoring System Equivalent Accuracy Evaluation of FORA Premium V10 Blood Glucose Monitoring System as Compared to Fora V30 Blood Glucose Monitoring System Abstract Objective: Both Fora Premium V10 and V30 blood glucose

More information

Performance Guide. icheck Iodine The test kit to measure iodine in salt

Performance Guide. icheck Iodine The test kit to measure iodine in salt Performance Guide icheck Iodine The test kit to measure iodine in salt Performance explained This Performance Guide is intended to explain the validity of our test kit icheck Iodine in a nutshell to facilitate

More information

Rethinking Traditional Lab QA/QC:

Rethinking Traditional Lab QA/QC: Rethinking Traditional Lab QA/QC: Understanding Weaknesses in Existing Requirements and Mastering Useful Methods and Metrics to Raise Your Lab s Analytical Accuracy October 1 st, 2013 Laboratory Quality

More information

1 PROTOCOL. Comparison Study Summary

1 PROTOCOL. Comparison Study Summary Comparison Study Summary OnSite Health 210 S. Michigan Street, Suite 110 South Bend, IN 46601 574-243-5108 ext. 203 July 27, 2015 1 PROTOCOL This internal evaluation was conducted on July 17 & 20, 2015

More information

The Virtues and Pitfalls of Implementing a New Test

The Virtues and Pitfalls of Implementing a New Test The Virtues and Pitfalls of Implementing a New Test James H. Nichols, Ph.D., DABCC, FACB Professor of Clinical Pathology, Microbiology and Immunology Associate Medical Director for Clinical Operations

More information

PointCare NOW TM Technical Note

PointCare NOW TM Technical Note PointCare NOW TM Technical Note Introduction to our Technology And Summary of Evaluation and Performance data 1 of 19 Introduction The PointCare NOW is a portable, and very fast, diagnostic instrument

More information

URGENT FIELD SAFETY NOTICE IMMEDIATE ACTION REQUIRED

URGENT FIELD SAFETY NOTICE IMMEDIATE ACTION REQUIRED Ref No: Date: 22.08.2018 Type of Action: PFSN18 Deviations of high (>4.5) CoaguChek INR values due to calibration with WHO reference standard rtf/16 SBN-CPS-2018-014 Field Safety Corrective Action (FSCA)

More information

1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803)

1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803) Comparison Study Summary Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC 29720 (803) 286-1480 February 10, 2016 1 PROTOCOL This evaluation was conducted on February 10, 2016 at Springs Memorial

More information

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE A. 510(k) Number: k103542 B. Purpose for Submission: Alternative blood glucose test strips for use with LifeScan OneTouch

More information

ImmunoCAP Systems. Optimized for allergy testing - Precision - Accuracy - Consistency

ImmunoCAP Systems. Optimized for allergy testing - Precision - Accuracy - Consistency ImmunoCAP Systems Optimized for allergy testing - Precision - Accuracy - Consistency 1 The ImmunoCAP systems from Phadia offer an optimal allergy testing solution for every laboratory, regardless of testing

More information

The Whats and Hows of Reference Intervals. Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney

The Whats and Hows of Reference Intervals. Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney The Whats and Hows of Reference Intervals Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney Surabaya Indonesia 2016 Acknowledgements Reference Intervals - Summary What are they

More information

2014 Continuing Compliance Master Series Best Practices in Alternative Assessment of Performance

2014 Continuing Compliance Master Series Best Practices in Alternative Assessment of Performance 2014 Continuing Compliance Master Series Best Practices in Alternative Assessment of Performance Brad S. Karon, MD, PhD, FCAP November 19, 2014 www.cap.org Today s Presenter Brad S. Karon, MD, PhD, FCAP

More information

AOAC Research Institute Performance Tested Methods SM Program. Measurement of Free Fatty Acids Using FASafe Standard Test Kit. Certificate Report

AOAC Research Institute Performance Tested Methods SM Program. Measurement of Free Fatty Acids Using FASafe Standard Test Kit. Certificate Report Performance Tested Methods SM Program Measurement of Free Fatty Acids Using FASafe Standard Test Kit Certificate Number 030405 June 23, 2003 SāfTest, Inc.,. 2414 West 12 th Street, Suite 4 Tempe, Arizona

More information

Proficiency Testing Evaluation

Proficiency Testing Evaluation Facility/Contact Phone: (573)265-8840 PCRMC Medical Group - Forest C Fax: (573)265-8884 1000 N Jefferson St Email (primary): odean@pcrmc.com; Email (secondary): (Please add pt@aafp.org to your electronic

More information

GlucCell TM SYSTEM USER S GUIDE ver 2.3 CELL CULTURE GLUCOSE METER. Important Information. Intended Use. Caution. About the System

GlucCell TM SYSTEM USER S GUIDE ver 2.3 CELL CULTURE GLUCOSE METER. Important Information. Intended Use. Caution. About the System GlucCell TM SYSTEM USER S GUIDE ver 2.3 Intended Use The GlucCell TM Cell Culture Glucose Monitoring System (The GlucCell TM System) is designed to quantitatively measure the concentration of glucose during

More information

Multiple studies are available concerning the use of

Multiple studies are available concerning the use of SPECIAL ARTICLE Evaluation of the Biosite Ò Quantitative Whole Blood D-dimer Assay and Comparison With the biomérieux VIDAS Ò D-dimer Exclusion Test Validation and Utility For Use in the Central Laboratory

More information

liquicolor (AMP Buffer, IFCC) Design Verification

liquicolor (AMP Buffer, IFCC) Design Verification Design Verification (AMP Buffer, IFCC) liquicolor 1 Introduction... 2 2 Imprecision... 2 3 arity and Detection Limit... 2 3.1 arity... 2 3.2 Detection Limit... 3 4 Comparison of Methods... 3 5 Stability...

More information

P re-analytical conditions are very important in laboratory assessment of hemostatic and coagulation systems

P re-analytical conditions are very important in laboratory assessment of hemostatic and coagulation systems OPEN SUBJECT AREAS: PRE-CLINICAL STUDIES PROTEASES BIOCHEMICAL ASSAYS BIOPHYSICAL CHEMISTRY Received 19 November 2013 Accepted 8 January 2014 Published 27 January 2014 Correspondence and requests for materials

More information

Comparison of Samples Obtained From 3.2% Sodium Citrate Glass and Two 3.2% Sodium Citrate Plastic Blood Collection Tubes Used in Coagulation Testing

Comparison of Samples Obtained From 3.2% Sodium Citrate Glass and Two 3.2% Sodium Citrate Plastic Blood Collection Tubes Used in Coagulation Testing Coagulation and Transfusion Medicine / GLASS VS PLASTIC IN HEMOSTASIS TESTING Comparison of Samples Obtained From 3.2% Sodium Citrate Glass and Two 3.2% Sodium Citrate Plastic Blood Collection Tubes Used

More information

Annual Report ERNDIM-EQAS Quantitative Amino Acids 2004

Annual Report ERNDIM-EQAS Quantitative Amino Acids 2004 Annual Report ERNDIM-EQAS Quantitative Amino Acids 2004 1. Purpose The purpose of the ERNDIM External Quality Assurance Scheme for Quantitative Organic Acids is the monitoring of the analytical quality

More information

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee College of American Pathologists (CAP) GH5 Survey Data: (updated 8/17) The American Diabetes Association (ADA) recommends that The A1C test should be performed using a method that is certified by the NGSP.

More information

Clinical Performance of the TRUE2go Blood Glucose Monitoring System Exceeds Minimum Criteria for Accuracy Using ISO 15197:2013

Clinical Performance of the TRUE2go Blood Glucose Monitoring System Exceeds Minimum Criteria for Accuracy Using ISO 15197:2013 linical Performance of the TRUE2go lood Glucose Monitoring System Exceeds Minimum riteria for Accuracy Using ISO 197:213 LINIAL STUY SUMMARY EVALUATION OJETIVES This clinical evaluation: 1. Evaluates the

More information

INDIVIDUAL STUDY TABLE REFERRING TO PART OF THE DOSSIER

INDIVIDUAL STUDY TABLE REFERRING TO PART OF THE DOSSIER 2. SYNOPSIS Title of Study: An Open-Label, 2-Cohort Study to Evaluate the 2-Way Interaction Between Multiple Doses of and a Single Dose of Rosuvastatin (Crestor ), to Assess the Dose Proportionality of,

More information

C. Bachmann This article was published as. Centre Hospitalier Universitaire Vaudois Number 3 in May 2000 CH 1011 Lausanne, Switzerland

C. Bachmann This article was published as. Centre Hospitalier Universitaire Vaudois Number 3 in May 2000 CH 1011 Lausanne, Switzerland The control of analytical accuracy and day to day precision helps for the follow-up of patients and is essential when using biochemical data from the literature. C. Bachmann This article was published

More information

Quality Specifications for POCT

Quality Specifications for POCT Quality Specifications for POCT the patient journey perspective Christopher P Price Department of Clinical Biochemistry, University of Oxford, Oxford, UK Quality Specifications fit-for-purpose QUALITY

More information

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee College of American Pathologists (CAP) GH5 Survey Data: (updated 12/17) The American Diabetes Association (ADA) recommends that The A1C test should be performed using a method that is certified by the

More information

BLOOD GLUCOSE METERS ACCURACY REQUIREMENTS

BLOOD GLUCOSE METERS ACCURACY REQUIREMENTS BLOOD GLUCOSE METERS ACCURACY REQUIREMENTS International Standard ISO 15197:2013 (Second Edition 15/05/2013) In vitro diagnostic test systems Requirements for blood-glucose monitoring systems for self-testing

More information

Rethinking Tradi.onal QA/QC: Weaknesses of Current Prac.ces; Six Sigma Metrics and Tools for Improvement

Rethinking Tradi.onal QA/QC: Weaknesses of Current Prac.ces; Six Sigma Metrics and Tools for Improvement Rethinking Tradi.onal QA/QC: Weaknesses of Current Prac.ces; Six Sigma Metrics and Tools for Improvement James O. Westgard Sten A. Westgard Westgard QC, Inc. Madison, WI www.westgard.com 1 Hospitals recognize

More information

System accuracy evaluation of FORA Test N Go Blood Glucose Monitoring System versus YSI 2300 STAT Plus glucose analyzer following ISO 15197:2013

System accuracy evaluation of FORA Test N Go Blood Glucose Monitoring System versus YSI 2300 STAT Plus glucose analyzer following ISO 15197:2013 System Accuracy Evaluation of Project number: Fora092614-01 System accuracy evaluation of Blood Glucose Monitoring System versus YSI 2300 STAT Plus glucose analyzer following ISO 15197:2013 Date: 13 th

More information

Four rules to remember: 1) Addition, subtraction, multiplication and division of SD and/or CV.

Four rules to remember: 1) Addition, subtraction, multiplication and division of SD and/or CV. Analytical Quality Specifications for Thyroid Hormones Bayer Nordic Users Meeting, 17. September 2001. Frode Engbaek, Ph. D., Department of Clinical Biochemistry, Aarhus Kommunehospital, DK-8000 Aarhus

More information

TRENDS IN TIME. EXTERNAL EVALUATION PROGRAM FOR Immmunoassays - Chemistry

TRENDS IN TIME. EXTERNAL EVALUATION PROGRAM FOR Immmunoassays - Chemistry Commissie voor Klinische Biologie Commission de Biologie Clinique EXTERNAL EVALUATION PROGRAM FOR Immmunoassays - Chemistry TRENDS IN TIME CM Van Campenhout N Hamers JC Libeer WIV/ISP/IPH Clinical Biology

More information

Annual Report ERNDIM-EQAS Quantitative Amino Acids 2002

Annual Report ERNDIM-EQAS Quantitative Amino Acids 2002 Annual Report ERNDIM-EQAS Quantitative Amino Acids 2002 1. Purpose The purpose of the ERNDIM External Quality Assurance Scheme for Quantitative Organic Acids is the monitoring of the analytical quality

More information

Evaluation Report. Eurolyser PT (INR) test kit (ST0180) on CUBE and smart analysers

Evaluation Report. Eurolyser PT (INR) test kit (ST0180) on CUBE and smart analysers Evaluation Report Eurolyser PT test kit (ST0180) on CUBE and smart analysers Locations Location 1: Eurolyser Diagnostica GmbH Operator: Simone Wieser Date: 30.06.2015 Specimens The specimens used for analysis

More information

Confirmation - A Practical Approach

Confirmation - A Practical Approach Data Mining i for Reference Interval Confirmation - A Practical Approach Graham Jones Chemical Pathologist St Vincent s Hospital, Sydney AACB Webinar 5 th June 2013 Summary A little (more) background Current

More information

Certificate of Analysis

Certificate of Analysis Siemens Healthcare Diagnostics Products GmbH Emil-von-Behring-Str. 76 35041 Marburg Germany Customer To whom it may concern Certificate of Analysis Material: 10446446 Kit-: 47066 Total lot size: 445 PCK

More information

" EXTERNAL QUALITY EVALUATION PROGRAM FOR POCT GLUCOSE TESTING years of experience

 EXTERNAL QUALITY EVALUATION PROGRAM FOR POCT GLUCOSE TESTING years of experience Commissie voor Klinische Biologie Commission de Biologie Clinique " EXTERNAL QUALITY EVALUATION PROGRAM FOR POCT GLUCOSE TESTING 8 3 years of experience CM Van Campenhout JC Libeer WIV/ISP/IPH Clinical

More information

Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory

Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory SQA National Meeting 29Mar2017 Carolyn Eberhardt, Principal Consultant, QC2 Mark Stiles, Senior Consultant, QC2 Comparison of Quality

More information

4/10/2017. Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory

4/10/2017. Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory SQA National Meeting 29Mar2017 Carolyn Eberhardt, Principal Consultant, QC2 Mark Stiles, Senior Consultant, QC2 Comparison of Quality

More information

Agenda. 15 Dec

Agenda. 15 Dec Implementing Traceability for Heterogeneous Analytes An Industry View JCTLM Symposium on Reference Measurement Systems for Biologicals, December 15, 2004 R. Miller 15 Dec. 2004 1 Agenda Recent trends in

More information

Selecting a Risk-Based SQC Procedure for a HbA1c Total QC Plan

Selecting a Risk-Based SQC Procedure for a HbA1c Total QC Plan 729488DSTXXX10.1177/1932296817729488Journal of Diabetes Science and TechnologyWestgard et al research-article2017 Original Article Selecting a Risk-Based SQC Procedure for a HbA1c Total QC Plan Journal

More information

LIPASE liquicolor. Design Verification. Multipurpose Reagent

LIPASE liquicolor. Design Verification. Multipurpose Reagent Design Verification LIPASE liquicolor Multipurpose Reagent CONTENTS 1 Introduction... 2 2 Imprecision... 2 3 Linearity and Detection Limit... 2 3.1 Linearity... 2 3.2 Detection Limit... 3 4 Recovery of

More information